Exelixis | Capitale Di Prestito



Loan Capital Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 0 0 2025-03
Amgen USD 53.76B 253M 2025-06
AstraZeneca USD 25.99B 1.9B 2025-06
Bayer EUR 31.71B 3.31B 2025-06
BioMarin Pharmaceutical USD 596.16M 512K 2025-06
Bristol-Myers Squibb USD 44.47B 1.69B 2025-06
Cytokinetics USD 713.04M 67.88M 2025-06
Eisai JPY 99.84B 9M 2025-06
Eli Lilly USD 34.18B 319.4M 2025-06
Exelixis USD 0 0 2025-04
Genmab DKK 132M 3M 2025-06
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 31.76M 883K 2025-06
Ionis Pharmaceuticals USD 625.49M 625.22M 2025-06
MacroGenics USD 0 0 2024-12
Merck USD 33.97B 484M 2025-06
Moderna USD 32M 3M 2025-06
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 24.06B 2.4B 2025-06
Pfizer USD 57.5B 137M 2025-06
Sanofi 11.79B 712M 2024-12
Takeda JPY 4.13T 168.47B 2025-06
Ultragenyx Pharmaceutical USD 782.75M 782.75M 2025-06
Xencor USD 94.74M 7.1M 2025-06


Exelixis Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.